Eugenio Fava

Drug Discovery in Early Research

Cellima Talks II

Drug Discovery in Early Research

Eugenio Fava, an accomplished scientist known for his passion and deep expertise in neuroscience and drug discovery, will share his insights into the drug discovery process, providing insight into the strategic approaches essential to understanding diseases, identifying key targets, and developing effective drugs using cutting-edge technologies.

During our session, Eugenio will provide an in-depth comparison between the roles of academic institutions and pharmaceutical companies in drug discovery, highlighting their unique challenges and contributions.

We will also explore with him the current obstacles researchers face throughout the drug discovery process. In addition, the discussion with Eugenio will address pressing issues in the field, including the critical role of artificial intelligence in drug discovery, the innovative use of 3D cell models, the potential of stem cell technologies, and the application of single-cell techniques to drug screening

Join us for an engaging conversation with Eugenio Fava as we explore the latest trends and challenges in drug discovery, providing a unique opportunity to gain valuable insights from a leading expert in the field.

more insights

Marc Bickle

Deep Phenotyping And AlphaFold

Marc Bickle discusses how Deep Phenotyping and AlphaFold are transforming early-stage drug discovery. Learn about cutting-edge technologies that enhance precision in oncology and neurodegenerative research, offering new insights and accelerating the development of personalized therapies through advanced AI-driven methods and high-content imaging.

Read more >
Thomas Müller

Guardians of Health

Thomas Müller, a distinguished scientist with over 30 years’ experience in ion channel research, talks about his journey from studying biology in Heidelberg and Glasgow to leading high-throughput screening at Bayer, where he’s been at the forefront of scientific innovation. In this enlightening session, Thomas shares his remarkable journey and delves into the fascinating world of ion channels.

Read more >
Respondents

HCI 2024 – Prospects

In order to better describe the current state and future prospects of High-Content Imaging, a market survey was conducted among researchers and organizations involved in early drug discovery worldwide.

Read more >

Future Prospects of High-Content Imaging